We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

58 hedge funds and large institutions have $1.61B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,332% more capital invested

Capital invested by funds: $36.2M → $1.61B (+$1.57B)

373% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 11

222% more funds holding

Funds holding: 18 → 58 (+40)

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

Holders
58
Holders Change
+40
Holders Change %
+222.22%
% of All Funds
1.03%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
52
Increased
4
Reduced
2
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCI
Bain Capital Investors
Massachusetts
+$788M
2
PA
Perceptive Advisors
New York
+$59M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$56M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$44.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$40.9M

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$7.32M
2
GL
Governors Lane
New York
-$6.91M
3
SRCM
Sage Rock Capital Management
New York
-$3.41M
4
CCM
Context Capital Management
California
-$2.82M
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$1.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
GL
26
Governors Lane
New York
$3.17M -$6.91M -532,000 -74%
Charles Schwab
27
Charles Schwab
California
$2.77M +$2.17M +166,710 New
LCP
28
LGT Capital Partners
Switzerland
$2.39M +$1.87M +144,254 New
Point72 Asset Management
29
Point72 Asset Management
Connecticut
$1.99M +$1.56M +120,000 New
LGM
30
Logos Global Management
California
$1.66M +$1.3M +100,000 New
Citigroup
31
Citigroup
New York
$1.52M +$1.19M +91,743 New
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$1.21M +$947K +72,886 New
Marshall Wace
33
Marshall Wace
United Kingdom
$1.12M +$880K +67,772 New
Northern Trust
34
Northern Trust
Illinois
$1.09M +$855K +65,805 New
ECM
35
ExodusPoint Capital Management
New York
$829K +$649K +49,992 New
HighTower Advisors
36
HighTower Advisors
Illinois
$752K +$589K +45,325 New
CCM
37
Consonance Capital Management
New York
$658K +$516K +39,697 New
Millennium Management
38
Millennium Management
New York
$656K +$514K +39,572 New
TD Asset Management
39
TD Asset Management
Ontario, Canada
$616K +$483K +37,158 New
BC
40
Brookfield Corp
Ontario, Canada
$603K +$472K +36,355 New
Verition Fund Management
41
Verition Fund Management
Connecticut
$587K +$77K +5,929 +20%
Goldman Sachs
42
Goldman Sachs
New York
$469K +$368K +28,309 New
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$373K +$292K +22,500 New
Bank of New York Mellon
44
Bank of New York Mellon
New York
$359K +$281K +21,637 New
PCM
45
Penserra Capital Management
California
$359K +$282K +21,701 New
HSBC Holdings
46
HSBC Holdings
United Kingdom
$357K +$273K +21,003 New
MFS
47
Mirabella Financial Services
United Kingdom
$281K +$220K +16,920 New
Stifel Financial
48
Stifel Financial
Missouri
$273K +$213K +16,436 New
VF
49
Virtu Financial
New York
$257K +$201K +15,478 New
Morgan Stanley
50
Morgan Stanley
New York
$238K +$187K +14,386 New
1
2
3

CERE Hedge Fund Activity: Q4 2020 in Review

58 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q4 2020, worth a combined $1.61B — up 4,332% from $36.2M a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new CERE positions and 11 closed out — a net gain of 41 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Bain Capital Investors, opening a new position worth an estimated $788M. The largest seller was 683 Capital Management, exiting entirely with an estimated $7.32M sold.

  • 58 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q4 2020, up from 18 in Q3 2020.
  • Funds reported $1.61B of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q4 2020, up 4,332% quarter-over-quarter.
  • 52 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q4 2020 and 11 closed out, a net change of +41 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q4 2020 was Bain Capital Investors, an estimated $788M added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q4 2020 was 683 Capital Management, an estimated $7.32M sold.

Based on aggregated 13F filings for Q4 2020.